Oral self-management of palbociclib (Ibrance®) using mobile technology protocol

Area of Science:

• Oncology
• Digital Health
• Patient Self-Management

Background:

• Oral anticancer medications are common but adherence can be challenging, impacting patient outcomes.
• Mobile technology offers a feasible platform for patient support and self-management in cancer care.

Purpose of the Study:

• To assess the feasibility and effectiveness of a mobile technology intervention for oral anticancer medication self-management.
• To evaluate patient and nurse satisfaction, acceptability, and usefulness of text message reminders.

Main Methods:

• A prospective, two-arm study randomized 220 metastatic breast cancer patients initiating palbociclib.
• The intervention group received unidirectional text message reminders via a secure web application on their smartphones.
• Data collected via surveys (quality of life, satisfaction) and nurse workload questionnaires; analyzed using intent-to-treat.

Main Results:

• Mobile technology interventions show promise in enhancing patient engagement with oral anticancer medication regimens.
• Text message reminders can improve medication self-management and patient satisfaction.
• The intervention is feasible, low-cost, and potentially improves nurse satisfaction in oncology care.

Conclusions:

• Mobile technology, specifically text messaging, is a viable tool to support oral anticancer medication adherence.
• This nurse-led intervention can empower patients in their cancer treatment and improve overall care experience.
• Further research can explore broader applications of digital health in oncology patient self-management.